The Centers for Medicare and Medicaid Services will now cover Medicare diagnostic lab tests that use DNA testing to determine the best treatment for patients with advanced cancer.
UK-based genomics data platform Global Gene Corp and American genetics company, Regeneron Genetics Center announced yesterday that they will collaborate to create the world’s largest project of its kind to study Indian population.
The full benefit of using AI-tools to make predictions and take alternative actions can’t be realised without careful consideration of the accompanying ethical pitfalls, say researchers.
FDNA has announced a Genomics Collaborative, with the aim of developing new precision medicine approaches that builds on partnerships already underway in the research community.
Google has announced a partnership with WuXi NextCODE, with the aim of enhancing its comprehensive genomics capabilities.
Researchers have developed a technique that allowed them to determine at diagnosis whether children with acute lymphoblastic leukaemia would relapse following treatment.
Scientists created an odd couple: a modified version of an immune-signalling protein and a coordinately modified receptor for this protein. The two bind only to each other, easing an advanced anti-cancer therapy’s side effects.
AstraZeneca has made the decision to push six early-stage experimental drugs into a new $250 million standalone biotech company focused on severe autoimmune diseases.
New research shows that a test for measuring the length of DNA endcaps called telomeres can alter treatment decisions for patients with certain types of bone marrow failures.